Vice President Head of Global Patent Department, Member of the Global Leadership Team
Mr. Robert DeBerardine was Vice President, Head of Global Patent Department and Member of the Global Leadership Team of Sanofi SA since 2011. He is responsible for all aspects of Sanofi patent procurement strategies and patent litigation. He previously served as Chief Patent Counsel for Abbott Laboratories and Assistant Chief Patent Counsel for Johnson & Johnson . He also worked as a trial attorney litigating patent cases when he was a partner at the law firms of Brobeck, Phleger and Harrison and earlier with the law firm of Jones Day, Reavis and Pogue . He joined Sanofi in March 2008. He holds a Bachelors Degree in Chemical Engineering cum laude from Lafayette College and a Juris Doctor Degree magna cum laude from Cornell Law School .
The company has Return on Asset of 4.95 % which means that on every $100 spent on asset it made $4.95 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 9.02 % implying that it generated $9.02 on every 100 dollars invested.
The company has 18.82 B in debt with debt to equity (D/E) ratio of 0.25 which may show that the company is not taking advantage of profits from borrowing. Sanofi has Current Ratio of 1.62 which is typical for the industry and considered as normal.
Sanofi researches, develops, manufactures, and markets healthcare solutions worldwide. Sanofi [SNY] is traded on New York Stock Exchange in USA. It is located in , Rue La BoParis, and employs 111,974 people. Filter other
Click "OK" to permanently delete this portfolio. Click "Cancel" if you have changed your mind.
Report was successfully generated.
You can either (1) right-mouth click the image to download it to your local drive or simply (2) copy and paste the
image data below to include picture of this graph on your web page without downloading the image file
Copy and paste above text right to your web page html
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide.
Please fill out our quick survey to help us provide your with a better service and user experience
Most of the functionality on our site is free to use.
However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented
capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory
NYSE Sanofi
-0.06% 
Equity Search
Advanced Search
Market Screener
Adviser Directory
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatility
Import Equities
Advice
Milan
Mexico
